Answers are grounded in this paper and cite their sources.
Oligonucleotides are an emerging class of drugs that are manufactured by solid-phase synthesis. As a chemical class, they have unique product-related impurities and degradants, characterization of which is an essential step in drug development. The synthesis cycle, impurities produced during the synthesis and degradation products are presented and discussed. The use of liquid chromatography combined with mass spectrometry for characterization and quantification of product-related impurities and degradants is reviewed. In addition, sequence determination of oligonucleotides by gas-phase fragmentation and indirect mass spectrometric methods is discussed.
No takes yet. Share an insight, caveat, or question.
Soheil Pourshahian (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: